Raymond James & Associates’s Alignment Healthcare ALHC Stock Holding History
Bought
Maintained
Sold
Other funds holding ALHC
GA
WP
DM
DCP
HRCM
Raymond James & Associates's ALHC Position: Q2 2024 in Review
Raymond James & Associates sold out of Alignment Healthcare (ALHC) in Q2 2024, closing a stake of 142,827 shares — an estimated $708K sold.
Raymond James & Associates first reported a position in ALHC in Q1 2024 and held it in 1 quarter. The position peaked at $708K in Q1 2024. 118 funds tracked by Wall St. Rank hold ALHC as of Q2 2024.
- Raymond James & Associates reported no remaining Alignment Healthcare position as of Q2 2024 after selling out during the quarter.
- Raymond James & Associates sold 142,827 Alignment Healthcare shares in Q2 2024, an estimated $708K.
- Raymond James & Associates first reported a position in Alignment Healthcare in Q1 2024 and held it in 1 quarter.
- Raymond James & Associates's Alignment Healthcare position peaked at $708K in Q1 2024.
- 118 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2024.
Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.